[HTML][HTML] Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals
J Park, LS Dean, B Jiyarom, LM Gangcuangco… - Frontiers in …, 2023 - frontiersin.org
Background Monocytes and macrophages play a pivotal role in inflammation during acute
SARS-CoV-2 infection. However, their contribution to the development of post-acute …
SARS-CoV-2 infection. However, their contribution to the development of post-acute …
[HTML][HTML] Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients
EV Ravkov, ESCP Williams, M Elgort… - Frontiers in …, 2024 - frontiersin.org
Introduction The clinical manifestations of acute severe acute respiratory syndrome
coronavirus type 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) …
coronavirus type 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) …
[HTML][HTML] Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals
A Rajamanickam, NP Kumar, AN Pandiarajan… - Scientific reports, 2021 - nature.com
Monocytes are thought to play an important role in host defence and pathogenesis of COVID-
19. However, a comprehensive examination of monocyte numbers and function has not …
19. However, a comprehensive examination of monocyte numbers and function has not …
Dynamic changes in monocytes subsets in COVID-19 patients
S Qin, Y Jiang, X Wei, X Liu, J Guan, Y Chen, H Lu… - Human immunology, 2021 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) is affecting the whole world
and threatening human health. We aim to investigate the immunological characteristics of …
and threatening human health. We aim to investigate the immunological characteristics of …
Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9+ monocytes associated with COVID-19 hospitalization
WJ Pandori, LE Padgett, A Alimadadi… - Journal of Leukocyte …, 2022 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection can result in severe immune dysfunction …
syndrome coronavirus 2 (SARS-CoV-2) infection can result in severe immune dysfunction …
[HTML][HTML] Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Introduction After more than two years the Coronavirus disease-19 (COVID-19) pandemic
continues to burden healthcare systems and economies worldwide, and it is evident that the …
continues to burden healthcare systems and economies worldwide, and it is evident that the …
[HTML][HTML] Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome
M Augustin, F Heyn, S Ullrich… - Frontiers in …, 2023 - frontiersin.org
Background Symptoms lasting longer than 12 weeks after severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) infection are called post-coronavirus disease …
syndrome coronavirus type 2 (SARS-CoV-2) infection are called post-coronavirus disease …
[HTML][HTML] Monocytes and Macrophages in COVID-19
COVID-19 is a contagious viral disease caused by SARS-CoV-2 that led to an ongoing
pandemic with massive global health and socioeconomic consequences. The disease is …
pandemic with massive global health and socioeconomic consequences. The disease is …
[HTML][HTML] A deep look into COVID-19 severity through dynamic changes in blood cytokine levels
DA Kleymenov, EN Bykonia, LI Popova… - Frontiers in …, 2021 - frontiersin.org
An excessive inflammatory response to SARS-CoV-2 is thought to be a major cause of
disease severity and mortality in patients with COVID-19. Longitudinal analysis of cytokine …
disease severity and mortality in patients with COVID-19. Longitudinal analysis of cytokine …
[HTML][HTML] COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
I Sánchez-Cerrillo, P Landete, B Aldave… - The Journal of …, 2020 - Am Soc Clin Investig
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …